Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV

In this small study, investigators genetically disrupted the HIV receptor CCR5 in CD4 T cells of aviremic persons who were infected with HIV. After reinfusion and during viremia, the modified cells declined at a significantly slower rate than did the unmodified cells. The ability to make site-specif...

Full description

Saved in:
Bibliographic Details
Published in:The New England journal of medicine Vol. 370; no. 10; pp. 901 - 910
Main Authors: Tebas, Pablo, Stein, David, Tang, Winson W, Frank, Ian, Wang, Shelley Q, Lee, Gary, Spratt, S. Kaye, Surosky, Richard T, Giedlin, Martin A, Nichol, Geoff, Holmes, Michael C, Gregory, Philip D, Ando, Dale G, Kalos, Michael, Collman, Ronald G, Binder-Scholl, Gwendolyn, Plesa, Gabriela, Hwang, Wei-Ting, Levine, Bruce L, June, Carl H
Format: Journal Article
Language:English
Published: Waltham, MA Massachusetts Medical Society 06-03-2014
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this small study, investigators genetically disrupted the HIV receptor CCR5 in CD4 T cells of aviremic persons who were infected with HIV. After reinfusion and during viremia, the modified cells declined at a significantly slower rate than did the unmodified cells. The ability to make site-specific modifications to (or “edit”) the human genome has been an objective in medicine since the recognition of the gene as the basic unit of heredity. 1 , 2 The challenge of genome editing is the ability to generate a single double-strand break at a specific point in the DNA molecule. Numerous agents, including meganucleases, oligonucleotides that form DNA triplexes, and peptide nucleic acids, have been tested and shown to be limited by inefficiency. 3 – 5 Another class of reagents, the zinc-finger nucleases (ZFNs), have proved versatile for genome editing, and the use of ZFNs is now well established . . .
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa1300662